Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
12.36
-0.80 (-6.08%)
At close: Sep 23, 2026, 4:00 PM EDT
12.36
0.00 (0.00%)
After-hours: Sep 23, 2026, 4:10 PM EDT
Design Therapeutics Market Cap
Design Therapeutics has a market cap or net worth of $773.51 million as of September 23, 2026. Its market cap has increased by 113.90% in one year.
Market Cap
773.51M
Enterprise Value
568.78M
1-Year Change
113.90%
Ranking
Category
Stock Price
$12.36
ChartMarket Cap Chart
Since the IPO on March 26, 2021, Design Therapeutics's market cap has decreased from $2.21B to $773.51M, a decrease of -64.94%. That is a compound annual growth rate of -17.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 773.51M | 44.77% |
| Dec 31, 2025 | 534.32M | 52.95% |
| Dec 31, 2024 | 349.35M | 135.41% |
| Dec 29, 2023 | 148.40M | -74.10% |
| Dec 30, 2022 | 572.92M | -51.55% |
| Dec 31, 2021 | 1.18B | -46.40% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Achieve Life Sciences | 821.16M |
| Aclaris Therapeutics | 809.59M |
| Climb Bio | 806.98M |
| Annexon | 801.92M |
| Gyre Therapeutics | 800.55M |
| BlossomHill Therapeutics | 788.77M |
| Pharming Group | 744.14M |
| Silence Therapeutics | 734.55M |